TDCS + Phonomotor Therapy for Aphasia
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Transcranial Direct Current Stimulation (tDCS) combined with Phonomotor Therapy for Aphasia?
Research shows that transcranial direct current stimulation (tDCS) can improve language skills in people with aphasia (language impairment) after a stroke. For example, one study found that tDCS significantly improved naming accuracy in patients, suggesting it can be a helpful addition to speech therapy.12345
Is Transcranial Direct Current Stimulation (tDCS) safe for humans?
How does the TDCS + Phonomotor Therapy treatment for aphasia differ from other treatments?
TDCS + Phonomotor Therapy is unique because it combines transcranial direct current stimulation (tDCS), which uses a mild electrical current to stimulate the brain, with phonomotor therapy, a type of speech therapy focused on improving language skills. This combination aims to enhance the effects of speech therapy by potentially increasing brain activity and language recovery, offering a novel approach compared to standard speech therapy alone.123610
What is the purpose of this trial?
This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life.The study aims to test a new approach to reading rehabilitation by combining Phono-Motor Treatment (PMT), a language therapy adapted to improve reading, with transcranial direct current stimulation (tDCS), a safe and painless brain stimulation technique. tDCS delivers a mild electrical current to the brain, which may enhance learning. This study will assess whether adding tDCS to PMT improves reading therapy outcomes.
Eligibility Criteria
This trial is for individuals who have aphasia, a language disorder often caused by stroke. Participants should struggle with reading due to their condition and are looking to improve their abilities through therapy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive different combinations of PMT and tDCS over six weeks, with assessments before, during, and after treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kessler Foundation
Lead Sponsor
Medical College of Wisconsin
Collaborator